1. Document de presse | 2021.11.26

    ComCor study: new results on places of infection with SARS-CoV-2 and analysis of the efficacy of messenger RNA vaccines against the Delta variant

    From May 23 to August 13, 2021, the Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos institute, conducted the fourth part of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus in France. The aim of the study was to identify the socio-demographic factors, places visited and...

  2. Document de presse | 2022.12.19

    Modelling has evaluated the role of antiviral treatment and vaccination in exiting the Zero-COVID strategy in Wallis and Futuna

    By June 2022, the Wallis and Futuna Islands, a French overseas territory, had successfully implemented a Zero-COVID strategy that significantly reduced the number of SARS-CoV-2 infections. From mid-June 2022, a gradual reopening of the borders was planned. However, the relatively low immunity in the population (due to limited vaccination coverage and the number of previous infections) and the...

  3. Fiche maladie | 2020.01.21

    COVID-19 (SARS-CoV-2 virus)

    The SARS-CoV-2 coronavirus, discovered in December 2019 in the province of Wuhan in China, is responsible for COVID-19. This highly contagious emerging infectious disease spreads by airborne transmission and surface contamination. Although COVID-19 can be asymptomatic, it can also cause a variety of symptoms, including severe respiratory distress that may prove fatal. Vaccination and basic health...

  4. Fiche maladie | 2019.10.02

    Influenza

    Influenza is a contagious respiratory infection caused by influenza viruses, which are unique due to their vast genetic variability. It is a public health issue because of the seasonal outbreaks that affect 2 to 6 million people in France every winter, with influenza-associated excess mortality estimated at approximately 10,000 deaths, mainly in vulnerable individuals. The pandemic risk...

  5. News | 2024.12.16

    Microbiota tailored skin humoral immunity and its potential for the development of novel vaccinal approaches

    Scientists have just made two major discoveries about a harmless bacterium, Staphylococcus epidermidis, present on our skin. A first study identifies the skin as a compartment able to develop highly protective antibody responses to skin colonizing microbe in the absence of inflammation or lymph node contribution. A second study concerns the development of a topical vaccine that can be applied...

  6. Fiche maladie | 2023.09.15

    Legionellosis

    Legionellosis is a collective term for diseases caused by Legionella bacteria, including the potentially fatal Legionnaires' disease. The most common species, Legionella pneumophila, causes a severe lung infection. The recent emergence of the disease can be explained by the affinity of Legionella bacteria for modern water supply systems. Although there is no vaccine for Legionnaires' disease, it...

  7. Document de presse | 2007.08.31

    Rabies - Press kit

      September 2007   > Rabies in France in 2007 > Rabies research at the Institut Pasteur > Louis Pasteur and rabies vaccination

  8. Fiche pays | 2017.08.21

    Poland

    Recommended vaccinationsRoutine vaccination:Vaccinations included in the vaccination schedule to be updatedBased on your travel plans:Tick-borne encephalitisIf staying in rural or forest areas between spring and autumn.Children: aged ≥1 yearMalaria preventionThere is no malaria in Poland.(Source: Weekly Epidemiological Bulletin [BEH] – Health Recommendations for Travelers). 

  9. News | 2023.11.27

    The spin-off Oncovita wins the France 2030 call for projects

     Oncovita, a spin-off from the Institut Pasteur, has won the call for projects "Innovation in biotherapies and bioproduction" as part of the France 2030 investment plan. The company will receive €4.5 million in funding from Bpifrance to support the development of its immunotherapeutic cancer vaccine, MVdeltaC. The company will also benefit from €3.5 million in private funding. This...

  10. News | 2020.04.16

    MOOC Vaccinology

    NEW EDITION OF THE FREE ON-LINE COURSE OF INSTITUT PASTEUR Realized with the support of the Fondation Ipsen, under the aegis of Fondation de France.Vaccines are among the most effective public health interventions currently available. Several diseases have been eradicated or reduced drastically through vaccination. Together, with antibiotics and clean water, vaccines have increased life...

Pages

Back to top